Section Arrow
QGEN.NYSE
- Qiagen N.V.
Quotes are at least 15-min delayed:2026/01/07 18:51 EST
After Hours
Last
 46.39
-0.92 (-1.94%)
Bid
23.62
Ask
70.86
High 47.31 
Low 46.39 
Volume 62.10K 
Regular Hours (Closed)
Last
 47.31
+0.3 (+0.64%)
Day High 
47.57 
Prev. Close
47.01 
1-M High
47.39 
Volume 
1.73M 
Bid
23.62
Ask
70.86
Day Low
46.785 
Open
47.12 
1-M Low
44.51 
Market Cap 
10.19B 
Currency 美元 
P/E 25.4 
%Yield 3.27 
10-SMA 45.71 
20-SMA 45.55 
50-SMA 45.81 
52-W High 51.875 
52-W Low 37.63 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
1.85/2.95
Enterprise Value
11.53B
Balance Sheet
Book Value Per Share
16.83
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
1.97B
Operating Revenue Per Share
9.01
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp7.38-0.03-0.40%879PE
After Hours 7.39 +0.01 +0.14%
OPKOPKO Health1.36+0.04+3.03%-- 
After Hours 1.3408 -0.0192 -1.41%
DHRDanaher Corp235.57-1.02-0.43%48.68PE
After Hours 234.8 -0.77 -0.33%
GHGuardant Health109.93-2.4-2.14%-- 
After Hours 111 +1.07 +0.97%
EXASExact Sciences Corp101.63-0.02-0.02%-- 
After Hours 101.47 -0.16 -0.16%
Industry overview quotes are at least 15 minutes delayed
Business Description
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.